Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Melanoma
Intervention:
Sponsor: University of Pittsburgh
Not yet recruiting - verified March 2010
Condition: Melanoma
Intervention: Biological: NY-ESO-1 protein; Poly-ICLC; Montanide
Sponsors: Bhardwaj, Nina, M.D.; Ludwig Institute for Cancer Research; Oncovir, Inc.
Not yet recruiting - verified March 2010
Condition: Melanoma
Interventions: Drug: bortezomib; Drug: sorafenib
Sponsors: Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute; Massachusetts General Hospital; Brigham and Women's Hospital; Bayer; Millennium Pharmaceuticals, Inc.
Not yet recruiting - verified March 2010
Condition: Malignant Melanoma
Intervention: Device: SciBase III Electrical Impedance Spectrometer
Sponsor: SciBase AB
Not yet recruiting - verified February 2010
Condition: Metastatic Melanoma
Interventions: Drug: Cisplatin; Biological: ALT-801
Sponsors: Altor Bioscience Corporation; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Cancer; Melanoma
Intervention: Drug: GSK1120212 Treatment
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Malignant Melanoma
Interventions: Drug: BMS-936558 (MDX1106-04); Drug: Ipilimumab
Sponsors: Bristol-Myers Squibb; Medarex; Ono Pharma
Recruiting - verified February 2010
Conditions: Advanced Cancers; Melanoma
Intervention: Procedure: Tumor Interstitial Fluid Pressure (IFP) assessments
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Condition: Melanoma
Interventions: Drug: Tasisulam; Drug: Paclitaxel
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Malignant Melanoma
Interventions: Drug: RO5185426; Drug: dacarbazine
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Conditions: Neoplasms; Unresectable Metastatic Cutaneous Melanoma
Intervention: Biological: Immunotherapeutic GSK2132231A
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Solid Tumors; Cancer
Interventions: Drug: XL184; Drug: Placebo; Drug: XL184
Sponsor: Exelixis
Recruiting - verified February 2010
Conditions: Melanoma; Skin Cancer
Interventions: Drug: MART-1: 26-35(27L) Peptide; Drug: Montanide ISA 51 VG; Drug: gp100:154-162 Peptide; Drug: PG 13/Faf2aB C 162D1 (anti- MART-1 F5 TCR); Drug: PG13-154-Ecll AIB (anti-gp100:154-162 TCR); Procedure: Radiation; Drug: Aldesleukin; Drug: Fludarabine; Drug: Cyclophosphamide; Genetic: Anti-gp 100:154 TCR PBL; Genetic: Anti-MART-1 F5 TCR PBL
Sponsor: National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Metastatic Melanoma
Intervention: Drug: Temozolomide, Decitabine, Panobinostat
Sponsors: University of Iowa; Holden Comprehensive Cancer Center; Novartis Pharmaceuticals
Recruiting - verified February 2010
Condition: Cancer
Intervention: Other: biologic sample preservation procedure
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Cancer
Interventions: Other: immunological diagnostic method; Other: physiologic testing
Sponsors: Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified June 2009
Conditions: Cancer; Melanoma; Solid Tumor Cancer
Interventions: Drug: Midazolam; Drug: GSK2118436; Drug: GSK2118436
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Malignant Melanoma
Interventions: Drug: ABI-007; Drug: Dacarbazine
Sponsors: Abraxis BioScience Inc.; University of Arizona
Recruiting - verified August 2009
Condition: Cancer
Intervention: Drug: Fluorescein
Sponsor: University of Utah
Recruiting - verified February 2010
Condition: Melanoma
Interventions: Drug: INXN-1001; Biological: INXN-3001
Sponsor: Intrexon Corporation
Recruiting - verified February 2010
Condition: Melanoma
Interventions: Drug: AntiCD137; Drug: AntiCD137; Drug: AntiCD137; Drug: AntiCD137; Drug: AntiCD137; Drug: Ipilimumab
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified November 2009
Condition: Resected Stage III Melanoma With Macroscopic Involvement
Interventions: Drug: GSK 2132231A; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Melanoma
Interventions: Biological: OncoVEXGM-CSF; Biological: GM-CSF
Sponsor: BioVex Limited
Recruiting - verified March 2010
Conditions: Renal Cell Carcinoma; Non-small Cell Lung Cancer; Malignant Melanoma; Epithelial Ovarian Cancer; Colorectal Adenocarcinoma
Intervention: Biological: MDX-1105
Sponsor: Bristol-Myers Squibb
Recruiting - verified March 2010
Conditions: Metastatic Castration-resistant Prostrate Cancer (mCRPC); Renal Cell Carcinoma (RCC); Malignant Melanoma (MEL); Non-small Cell Lung Cancer (NSCLC)
Intervention: Biological: MDX-1106
Sponsor: Bristol-Myers Squibb
Recruiting - verified March 2010
Condition: Stage IV Metastatic Melanoma
Interventions: Biological: Autologous dendritic cells generated from CD34+ hematopoietic progenitors and pulsed with melanoma and viral peptides; Biological: Saline placebo
Sponsor: Baylor Research Institute
Recruiting - verified February 2010
Condition: Melanoma (Skin)
Intervention: Drug: dasatinib
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Solid Tumors and Lymphoma
Intervention: Drug: GSK1120212
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Metastatic Melanoma
Intervention: Biological: Alpha-Gal Glycosphingolipids
Sponsor: University of Massachusetts
Recruiting - verified March 2010
Condition: Melanoma (Skin)
Intervention: Biological: aldesleukin
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2009
Condition: High Risk Stage III Melanoma
Interventions: Drug: ipilimumab; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Recruiting - verified January 2010
Condition: Melanoma (Skin)
Interventions: Biological: ALVAC-CEA vaccine; Biological: aldesleukin; Biological: autologous anti-gp100:154-162 T-cell receptor gene-engineered peripheral blood lymphocytes; Drug: cyclophosphamide; Drug: fludarabine phosphate
Sponsor: National Cancer Institute (NCI)
Recruiting - verified October 2008
Condition: Metastatic Melanoma
Interventions: Drug: Disulfiram; Drug: Arsenic trioxide
Sponsor: University of California, Irvine
Recruiting - verified March 2010
Condition: Cancer
Interventions: Drug: fentanyl sublingual spray; Other: questionnaire administration
Sponsor: Insys Therapeutics Inc
Recruiting - verified October 2008
Conditions: Brain Neoplasms; Melanoma
Interventions: Drug: Lomustine; Drug: Temozolomide; Drug: Thalidomide
Sponsors: M.D. Anderson Cancer Center; Celgene Corporation
Recruiting - verified March 2010
Condition: Melanoma
Interventions: Drug: Temozolomide (TMZ); Drug: Pegylated Interferon Alpha-2b (PGI)
Sponsors: M.D. Anderson Cancer Center; Schering-Plough
Recruiting - verified March 2010
Condition: Melanoma
Intervention: Drug: Ipilimumab
Sponsor: Bristol-Myers Squibb
Available - verified March 2010
Conditions: Colorectal Neoplasms; Melanoma; Prostatic Neoplasms; Renal Cell Carcinoma; Neoplasms
Intervention: Drug: CP-675,206
Sponsor: Pfizer
Recruiting - verified February 2010
Condition: Melanoma
Interventions: Biological: Dendritic Cell Immunization; Drug: Cyclophosphamide; Drug: Fludarabine; Biological: T Cells; Biological: Interleukin-2
Sponsors: M.D. Anderson Cancer Center; Chiron Corporation
Recruiting - verified March 2010
Condition: Metastatic Melanoma
Interventions: Drug: Vinorelbine; Drug: Docetaxel; Drug: Sargramostim
Sponsor: University of California, Irvine
Recruiting - verified March 2010
Condition: Cancer
Interventions: Drug: isolated perfusion; Drug: melphalan
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2009
Condition: Melanoma (Skin)
Intervention: Biological: PEG-interferon alfa-2b
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Melanoma (Skin)
Interventions: Biological: recombinant interferon alfa; Other: clinical observation
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia Group B; NCIC Clinical Trials Group; Children's Oncology Group
Recruiting - verified March 2010
All Categories ... by Medical Condition » ... Cancers » ... Melanoma 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
